Significance of COX-2 expression in human esophageal squamous cell carcinoma

Carcinogenesis

Volumn 27, Issue 6, 2006, Pages 1214-1221

  Zhi, Huiying ^a   Wang, Lin ^a   Zhang, Jian ^a   Zhou, Chuannong ^a   Ding, Fang ^a   Luo, Aiping ^a   Wu, Min ^a   Zhan, Qimin ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOOXYGENASE 2; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; SMALL INTERFERING RNA;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVITY; ENZYME REGULATION; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCOSA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UPREGULATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; MICE; MICE, NUDE; NITROBENZENES; RNA, SMALL INTERFERING; SULFONAMIDES;

EID: 33745597894     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi304     Document Type: Article

References (37)

1. O'Banion, M.K., Winn, V.D. and Young, D.A. (1992) cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxy-genase. Proc. Natl Acad. Sci. USA, 89, 4888-4892.
2. Fosslien, E. (2000) Molecular pathology of cyclooxygenase-2 in neoplasia. Ann. Clin. Lab. Sci., 30, 3-21.
3. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
4. Murata, H., Kawano, S., Tsuji, S., Tsuji, M., Sawaoka, H., Kimura, Y., Shiozaki, H. and Hori, M. (1999) Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in hurnan gastric carcinoma. Am. J. Gastroenterol., 94, 451-455.
5. Okami, J., Yamamoto, H., Fujiwara, Y. et al. (1999) Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res., 5, 2018-2024.
6. Half, E., Tang, X.M., Gwyn, K., Sahin, A., Wathen, K. and Sinicrope, F.A. (2002) Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res., 62, 1676-1681.
7. Khuri, F.R., Wu, H., Lee, J.J., Kemp, B.L., Lotan, R., Lippman, S.M., Feng, L., Hong, W.K. and Xu, X.C. (2001) Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res., 7, 861-867.
8. Ristimaki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., Joensuu, H. and Isola, J. (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res., 62, 632-635.
9. Shono, T., Tofilon, P.J., Bruner, J.M., Owolabi, O. and Lang, F.F. (2001) Cyclooxygenase-2 expression in human gliomas: Prognostic significance and molecular correlations. Cancer Res., 61, 4375-4381.
10. Yamamoto, K., Kitayama, W., Denda, A., Morisaki, A., Kuniyasu, H. and Kirita, T. (2003) Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide. Cancer Lett., 199, 121-129.
11. Fukutake, M., Nakatsugi, S., Isoi, T., Takahashi, M., Ohta, T., Mamiya, S., Taniguchi, Y., Sato, H., Fukuda, K., Sugimura, T. and Wakabayashi, K. (1998) Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis, 19, 1939-1942.
12. Oshima, M., Dinchuk, J.E., Kargman, S.L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J.M., Evans, J.F. and Taketo, M.M. (1996) Suppression of intestinal polyposis in Ape delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
13. Funkhouser, E.M. and Sharp, G.B. (1995) Aspirin and reduced risk of esophageal carcinoma. Cancer, 76, 1116-1119.
14. Corley, D.A., Kerlikowske, K., Verma, R. and Buffler, P. (2003) Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis. Gastroenterology, 124, 47-56.
15. Shamma, A., Yamamoto, H., Doki, Y., Okami, J., Kondo, M., Fujiwara, Y., Yano, M., Inoue, M., Matsuura, N., Shiozaki, H. and Monden, M. (2000) Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin. Cancer Res., 6, 1229-1238.
16. Zhi, H., Zhang, J., Hu, G., Lu, J., Wang, X., Zhou, C., Wu, M. and Liu, Z. (2003) The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma. Int. J. Cancer, 106, 327-333.
17. Yu, H.P., Xu, S.Q., Liu, L., Shi, L.Y., Cai, X.K., Lu, W.H., Lu, B., Su, Y.H. and Li, Y.Y. (2003) Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus. Cancer Lett., 198, 193-201.
18. Kase, S., Osaki, M., Honjo, S., Hashimoto, K., Adachi, H. Tsujitani, S. and Ito, H. (2004) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma. Pathobiology, 71, 84-92.
19. Zhang, W., Wang, L., Chang, A., Jin, Y. and Rao, J. (2003) Inummohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China. Cancer Detect. Prev., 27, 243-249.
20. Trifan, O.C. and Hla, T. (2003) Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J. Cell. Mol. Med., 7, 207-222.
21. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. and Tobe, T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer, 69, 277-284.
22. Han, Y., Wei, F., Xu, X., Cai, Y., Chen, B., Wang, J., Xia, S., Hu, H., Huang, X., Han, Y., Wu, M. and Wang, M. (2002) Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Clin. J. Med. Genet., 19, 455-457.
23. Li, M., Wu, X. and Xu, X.C. (2001) Induction of apoptosis by cyclooxygenase-2 inhibitor NS398 though a cytochome C-dependent pathway in esophageal cancer cells. Int. J. Cancer, 93, 218-223.
24. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S. and Otomo, S. (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.
25. Gierse, J.K., Hauser, S.D., Creely, D.P., Koboldt, C., Rangwala, S.H., Isakson, P.C. and Seibert, K. (1995) Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem. J., 305, 479-484.
26. Yip-Schneider, M.T., Sweeney, C.J., Jung, S.H., Crowell, P.L. and Marshall, M.S. (2001) Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J. Pharmacol. Exp. Ther., 298, 976-985.
27. 1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference. Oncogene, 22, 8653-8661.
28. Toyoshima, T., Kamijo, R., Takizawa, K., Sumitani, K., Ito, D. and Nagunto, M. (2002) Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21. Br. J. Cancer, 86, 1150-1156.
29. Cheng, J., Imanishi, H., Liu, W., Nakamura, H., Morisaki, T., Higashino, K. and Hada, T. (2004) Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines. Cancer Sci., 95, 666-673.
30. Dempke, W., Rie, C., Grothey, A. and Schmoll, H.J. (2001) Cyclooxygenase-2: A novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol., 127, 411-417.
31. Fodera, D., D'Alessandro, N., Cusimano, A., Poma, P., Notarbartolo, M., Lampiasi, N., Montalto, G. and Cervello, M. (2004) Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors. Ann. NY Acad. Sci., 1028, 440-449.
32. Ding, X.Z., Tong, W.G. and Adrian, T.E. (2000) Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res., 20, 2625-2631.
33. Sun, Y., Tang, X.M., Half, E., Kuo, M.T. and Sinicrope, F.A. (2002) Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res., 62, 6323-6328.
34. Masferrer, J.L., Leahy, K.M., Koki, A.T., Zweifel, B.S., Settle, S.L., Woerner, B.M., Edwards, D.A., Flickinger, A.G., Moore, R.J. and Seibert, K. (2000) Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res., 600, 1306-1311.
35. Sui, G., Soohoo, C., Affar, El.B., Gay, F., Shi, Y., Forrester, W.C. and Shi, Y. (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA, 99, 5515-5520.
36. Bantounas, I., Phylactou, L.A. and Uney, J.B. (2004) RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol., 33, 545-557.
37. Miyagishi, M. and Taira, K. (2004) RNAi expression vectors in mammalian cells. Methods Mol. Biol., 252, 483-491.